期刊文献+

非甾体类抗炎药的不良反应研究进展 被引量:60

Advances in Search for Adverse Reactions of Non-steroidal Anti-inflammatory Drugs
下载PDF
导出
摘要 非甾体抗炎药是临床上常用的解热镇痛药物,由于该类药物确切的疗效和不良反应之间的矛盾,长期以来一直受到研究者的关注,如何提高疗效,有效预防不良反应也一直成为该研究领域的热点,随着药品不良反应研究、药品经济学、药物基因学、循证医学等相关学科的发展,对该类药物不良反应发生、预防、发展、转归的研究也逐渐深入。这将为临床合理使用非甾体抗炎药提供更多的科学依据。 Non-steroidal anti-inflammatory drugs (NSAIDs) is such kind of common used drugs that have a long history of argument on the controversy about its defined efficacy and adverse reaction. Much effort has been done in this field to reduce the adverse reactions as much as possible without at the expense of improving high efficacy. In the past decade, the development of drug adverse reaction research, pharmacoecnomics, pharmacogenetics and evidence-based medicine have put deeper insight in the research of the etiology, prevention development, and outcome of the adverse reaction caused by NSAIDs,which in turn will provide more scientific clue to reasonable selection of NSAIDs in clinical practice.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2003年第1期57-62,共6页 The Chinese Journal of Clinical Pharmacology
关键词 非甾体类抗炎药 药物不良反应 机制 药品经济学 药物基因学 non-steroidal anti-inflammatory drugs drug adverse reaction mechanism pharmacoecnomics pharmacogenetics
  • 相关文献

参考文献38

  • 1[1]Lichtenstein D, Syngal S, Wlfe MM. Non-steroidal antiinflammatory drugs and the gastrointestinal tract. Arthritis Rherm,1995;38:1:5~18.
  • 2[2]Bjarnason I, Macpherson A, Somasundaram S, et al. Lower bowel toxicity of non-steroidal anti-inflammatory drugs. Lewis A: Non-steroidal Anti-Inflammatory Drugs, Mechanisms and Clinical Uses. New York: NY, Marcel Dekker, 1994;145~157.
  • 3[3]Marie R, Griffin, MD. Epidemiology of non-steroidal antiinflammatory drug-associated gastrointestinal injury. Am J Med.1998;104: 23~28.
  • 4[4]Fujiwara Y, Schmassman A, Arakawa T, et al. Indomethacin interferes with epidermal growth factor binding and proliferative response of KATO Ⅲ cells. Digestion, 1995;56:364~369.
  • 5[5]Henry D, Robertson J. Non-steroidal anti-inflammatory drugs and peptic ulcer hospitalization rates in New South Wales.Gastroenterology. 1993; 104:1083~ 1091.
  • 6[6]Fries JF, Williams CA, Michel BA et al. Nonsteroidal antiinflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med, 1991 ;91:213 ~222.
  • 7[7]Gutthamm SP, García LA, Raiford DS. Individual nonsteroidal anti-inflammatory drugs and the risk of hospitalization for upper gastrointestinal bleeding and perforation in saskatche wan: a nested case-control study. Pharmacoepidemiol Drug Safety. 1994;3:S63.
  • 8[8]Loeb DS, Talley NJ, Ahlquist DA, et al. Long-term non-steroidal anti-inflammatorydrug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology, 1992;102 :1899~1905.
  • 9[9]Langman MJS, Weil J, Wainwright P, et al. Risk of bleeding peptic ulcer associated with individual non-steroidal antiinflammatory drugs. Lancet, 1994 ;34 3 :107 5-107 8
  • 10[10]Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: Physiologic foundations and clinical implications. am J Med, 1999;106:13~23.

同被引文献614

引证文献60

二级引证文献393

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部